Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy.

Purpose: Intensity-modulated radiation therapy (IMRT) enables radiation oncologists to optimally spare organs at risk while achieving homogeneous dose distribution in the target volume. Despite great advances in technology, xerostomia is one of the most detrimental long-term side effects after multi...

Descripción completa

Detalles Bibliográficos
Publicado en:Strahlentherapie und Onkologie Vol. 197; no. 3; pp. 219 - 231
Autores principales: Tribius, Silke, Haladyn, Sven, Hanken, Henning, Busch, Chia-Jung, Krüll, Andreas, Petersen, Cordula, Bergelt, Corinna
Formato: Journal Article
Publicado: Springer Nature Mar2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=148804021&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 148804021
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01797158
        NZE
      jtl: Strahlentherapie und Onkologie
      issn: 01797158
      maglogo: N
    pubinfo:
      dt: Mar2021
      vid: 197
      iid: 3
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        148804021
        147882876
        148804021
        NLM33377992
        10.1007/s00066-020-01737-2
        NLM33377992
        148804021
      ppf: 219
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy.
      aug:
        au:
          Tribius, Silke
          Haladyn, Sven
          Hanken, Henning
          Busch, Chia-Jung
          Krüll, Andreas
          Petersen, Cordula
          Bergelt, Corinna
        affil: Department of Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
      sug:
        subj:
          Head and Neck Neoplasms Radiotherapy
          Quality of Life
          Survivors
          Parotid Gland Radiation Effects
          Female
          Aged
          Male
          Prospective Studies
          Middle Age
          Radiotherapy, Conformal Methods
          Impact of Events Scale
          Scales
          Ferrans and Powers Quality of Life Index
          Questionnaires
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Purpose: Intensity-modulated radiation therapy (IMRT) enables radiation oncologists to optimally spare organs at risk while achieving homogeneous dose distribution in the target volume. Despite great advances in technology, xerostomia is one of the most detrimental long-term side effects after multimodal therapy in patients with locally advanced head and neck cancer (HNC). This prospective observational study examines the effect of parotid sparing on quality of life in long-term survivors.Patients and Methods: A total of 138 patients were grouped into unilateral (n = 75) and bilateral (n = 63) parotid sparing IMRT and questioned at 3, 24, and 60-month follow-up using the European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-H&N35 questionnaires. Treatment-related toxicity was scored according to the RTOG/EORTC toxicity criteria. Patients' QoL 24 and 60 months after IMRT was analyzed by ANCOVA using baseline QoL (3 months after IMRT) as a covariate.Results: Patients with bilateral and unilateral parotid-sparing IMRT surviving 60 months experience similar acute and late side effects and similar changes in QoL. Three months after IMRT, physical and emotional function as well as fatigue, nausea and vomiting, pain, dyspnea, and financial problems are below (function scales) or above (symptom scales) the threshold of clinical importance. In both groups, symptom burden (EORTC H&N35) is high independent of parotid sparing 3 months after IMRT and decreases over time in a similar pattern. Pain and financial function remain burdensome throughout.Conclusion: Long-term HNC survivors show a similar treatment-related toxicity profile independent of unilateral vs. bilateral parotid-sparing IMRT. Sparing one or both parotids had no effect on global QoL nor on the magnitude of changes in function and symptom scales over the observation period of 60 months. The financial impact of the disease and its detrimental effect on long-term QoL pose an additional risk to unmet needs in this special patient population. These results suggest that long-term survivors need and most likely will benefit from early medical intervention and support within survivorship programs.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N